Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion
- PMID: 3137195
- PMCID: PMC5917579
- DOI: 10.1111/j.1349-7006.1988.tb02224.x
Dose-dependent induction of liver and thyroid neoplastic lesions by short-term administration of 2-amino-3-methylimidazo[4,5-f]quinoline combined with partial hepatectomy followed by phenobarbital or low dose 3'-methyl-4-dimethylaminoazobenzene promotion
Abstract
Dietary administration of 0.1, 0.05, or 0.025% 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) for two weeks combined with partial hepatectomy at the end of the first week and followed by long-term treatment with phenobarbital (PB) or 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB) from week 3 to week 86 resulted in dose-dependent development of liver and thyroid neoplastic and preneoplastic lesions. Quantitation of glutathione S-transferase placental form (GST-P)-positive hepatocellular focal populations revealed a significant correlation of IQ concentration with lesion area, with a yield approximately equal to that generated by a similar dose of 2-acetylaminofluorene. The fact that IQ was less toxic therefore allowed greater yields of hepatocellular carcinomas to be induced. The development of thyroid tumors initiated by the IQ treatment was significantly enhanced by the administration of PB, whereas Zymbal gland tumors induced by IQ did not show any correlation with either PB or 3'-Me-DAB treatment.
Similar articles
-
Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.Carcinogenesis. 1990 Apr;11(4):549-52. doi: 10.1093/carcin/11.4.549. Carcinogenesis. 1990. PMID: 2322995
-
Effect of timing of partial hepatectomy on the induction of preneoplastic liver foci in rats given hepatocarcinogens.Cancer Lett. 1986 Jul;32(1):15-23. doi: 10.1016/0304-3835(86)90034-0. Cancer Lett. 1986. PMID: 2427192
-
Promoting effects of phenobarbital and 3'-methyl-4-dimethylaminoazobenzene on the appearance of gamma-glutamyltranspeptidase positive foci in rat liver pretreated with varying doses of diethylnitrosamine.Cancer Lett. 1985 Sep 15;28(2):127-33. doi: 10.1016/0304-3835(85)90067-9. Cancer Lett. 1985. PMID: 2865001
-
Genetic resistance to chemical hepatocarcinogenesis in the DRH rat strain.Comp Med. 2004 Aug;54(4):373-7. Comp Med. 2004. PMID: 15357316 Review.
-
Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.Mutagenesis. 2016 May;31(3):341-6. doi: 10.1093/mutage/gev049. Epub 2015 Jul 7. Mutagenesis. 2016. PMID: 26152227 Review.
Cited by
-
Exposure to heterocyclic amines.Environ Health Perspect. 1993 Mar;99:129-34. doi: 10.1289/ehp.9399129. Environ Health Perspect. 1993. PMID: 8319610 Free PMC article.
-
Number of simultaneously expressed enzyme alterations correlates with progression of N-ethyl-N-hydroxyethylnitrosamine-induced hepatocarcinogenesis in rats.Jpn J Cancer Res. 1993 Dec;84(12):1237-44. doi: 10.1111/j.1349-7006.1993.tb02828.x. Jpn J Cancer Res. 1993. PMID: 7904986 Free PMC article.
-
Effects of modifying agents on conformity of enzyme phenotype and proliferative potential in focal preneoplastic and neoplastic liver cell lesions in rats.Jpn J Cancer Res. 1992 Nov;83(11):1154-65. doi: 10.1111/j.1349-7006.1992.tb02739.x. Jpn J Cancer Res. 1992. PMID: 1336490 Free PMC article.
References
-
- ) Matsukura , N. , Kawachi , T. , Morino , K. , Ohgaki , H. and Sugimura , T.Carcinogenicity in mice of mutagenic compounds from a tryptophan pyrolysate . Science , 213 , 346 ( 1981. ). - PubMed
-
- ) Ishikawa , T. , Takayama , S. , Kitagawa , T. , Kawachi , T. , Kinebuchi , M. , Matsukura , N. , Uchida , E. and Sugimura , T.In vivo experiments on tryptophan pyrolysis products . In “ Naturally Occurring Carcinogens‐Mutagens and Modulators of Carcinogenesis ,” ed. Miller E. C. , Miller J. A. , Hirono I. , Sugimura T. and Takayama S. , pp. 159 – 167 ( 1981. ). Japan Scientific Societies Press, Tokyo/University Park Press; , Baltimore .
-
- ) Hosaka , S. , Matsushima , T. , Hirono , I. and Sugimura , T.Carcinogenic activity of 3‐amino‐1‐methyl‐5H‐pyrido[4,3 ‐b]indole (Tr‐P‐2), a pyrolysis product of tryptophan . Cancer Lett. , 13 , 23 – 28 ( 1981. ). - PubMed
-
- ) Takayama , S. , Nakatsuru , Y. , Ohgaki , H. , Sato , S. and Sugimura , T.Carcinogenicity in rats of a mutagenic compound, 3‐amino‐1,4‐dimethyl‐5H‐pyrido[4,3‐b]indole, from tryptophan pyrolysate . Jpn. J. Cancer Res. (Gann) , 76 , 815 – 817 ( 1985. ). - PubMed
-
- ) Takayama , S. , Masuda , M. , Mogami , M. , Ohgaki , H. , Sato , S. and Sugimura , T.Induction of cancers in the intestine, liver and various other organs of rats by feeding mutagens from glutamic acid pyrolysate . Gann , 75 , 207 – 213 ( 1984. ). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials